Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.395
+0.005 (0.36%)
Jun 3, 2026, 3:36 PM EDT - Market open
Humacyte Market Cap
Humacyte has a market cap or net worth of $309.72 million as of June 3, 2026. Its market cap has decreased by -10.86% in one year.
Market Cap
309.72M
Enterprise Value
336.56M
1-Year Change
-10.86%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $309.72M, an increase of 149.15%. That is a compound annual growth rate of 18.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 308.61M | 66.48% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 324.30M |
| Neumora Therapeutics | 319.70M |
| InflaRx | 319.63M |
| Rocket Pharmaceuticals | 315.57M |
| Palisade Bio | 311.41M |
| DiaMedica Therapeutics | 310.91M |
| Silence Therapeutics | 301.83M |
| Lineage Cell Therapeutics | 301.65M |